FAAP20

FAAP20 is an integral subunit of the Fanconi anemia (FA) nuclear core complex that couples ubiquitin signaling at damaged chromatin to FA-pathway activation and DNA interstrand crosslink (ICL) repair (PMID:22343915, PMID:22396592, PMID:22705371). It binds FANCA through a defined interaction that reciprocally stabilizes FAAP20, and its loss produces hallmark FA defects—crosslinker hypersensitivity, chromosome aberrations, and reduced FANCD2 monoubiquitination (PMID:22343915, PMID:22396592, PMID:22705371). FAAP20 recognizes ubiquitinated chromatin through a ubiquitin-binding zinc-finger (UBZ) module whose binding surface is extended by a C-terminal tail that folds into a rigid β-loop on ubiquitin engagement, with an invariant C-terminal tryptophan contacting the ubiquitin I44 patch; this activity is dispensable for FANCA binding but required for DNA-damage-induced chromatin loading of FANCA (PMID:22343915, PMID:22396592, PMID:22705371, PMID:25414354, PMID:25799058). FAAP20 preferentially reads the K63-linked ubiquitin product generated by the RNF8–UBC13 pair, and both this E3/E2 activity and FAAP20 ubiquitin binding are required to recruit the FA core complex to ICL sites (PMID:22705371). A distinct UBZ surface engages the Rev1 BRCT domain, and ubiquitin binding enhances this interaction, linking FAAP20 to translesion-polymerase recruitment (PMID:26318859). Beyond ICL repair, FAAP20 acts in double-strand-break repair: it stimulates FANCA strand-annealing activity in vitro, supports single-strand annealing in a FANCA-dependent manner, and promotes homologous recombination and RAD51 focus formation, with its loss sensitizing cells to ionizing radiation and PARP inhibition (PMID:37620397). FAAP20 abundance is tightly regulated by a phosphodegron: GSK3β phosphorylation licenses SCF-FBW7-mediated polyubiquitination and proteasomal turnover (PMID:27232758), which is opposed by PIN1-catalyzed prolyl isomerization that recruits PP2A to reverse the phosphorylation (PMID:30789902) and by p300/CBP acetylation of K152 that competes with ubiquitination at the same lysine (PMID:32763975). Knockout mice display a mild FA-like phenotype with hematopoietic reconstitution defects and MMC-induced pancytopenia (PMID:25917546).

1. 2012 High

   Establishing FAAP20 as a bona fide FA core complex subunit answered whether this factor operates within the canonical FA machinery and identified FANCA as its stabilizing anchor.

   Evidence Co-IP, FANCA interaction mapping, and protein stability assays in human cells

   PMID:22343915 PMID:22396592

   Open questions at the time

   • Did not define the structural basis of the FAAP20-FANCA interface
   • Mechanism by which FANCA stabilizes FAAP20 not resolved
2. 2012 High

   Discovery of the UBZ domain and its K63-ubiquitin binding showed how FAAP20 reads damaged chromatin and separated its ubiquitin-recognition role from FANCA binding.

   Evidence In vitro ubiquitin-binding assay, domain mutagenesis, and chromatin fractionation

   PMID:22343915 PMID:22396592 PMID:22705371

   Open questions at the time

   • Did not identify the in vivo source of the K63 chains at that point
   • Atomic-level recognition mode not yet defined
3. 2012 High

   Loss-of-function studies established FAAP20 as functionally required for FA core complex ubiquitin ligase output, linking it to FANCD2 monoubiquitination and ICL resistance.

   Evidence Somatic knockouts with FANCD2 monoubiquitination, clonogenic survival, and cytogenetics

   PMID:22343915 PMID:22396592 PMID:22705371

   Open questions at the time

   • Did not distinguish chromatin-recruitment defect from catalytic defect
   • Non-ICL repair roles unexamined
4. 2012 High

   Identifying RNF8–UBC13 as the upstream K63 source and showing its requirement for FAAP20 recruitment placed FAAP20 in a defined signaling cascade at crosslink sites.

   Evidence Co-IP, ubiquitin-binding assays, immunofluorescence foci, and RNF8/RNF168 knockdown epistasis

   PMID:22705371

   Open questions at the time

   • Did not establish the chromatin substrate ubiquitinated by RNF8 in this context
   • Quantitative kinetics of recruitment unresolved
5. 2015 High

   Structural studies of the UBZ–ubiquitin interaction defined the molecular recognition mechanism, revealing a C-terminal tail extension and key residues whose mutation abolishes binding and damage-site accumulation.

   Evidence NMR and 1.9 Å crystal structure of UBZ with diubiquitin, SPR, mutagenesis, and cellular damage-site assays

   PMID:25414354 PMID:25799058

   Open questions at the time

   • SPR showed similar affinity across M1/K48/K63 linkages, leaving in vivo linkage selectivity to be explained by context
   • Did not capture full-length FAAP20 conformation
6. 2015 Medium

   Mapping a distinct UBZ surface for Rev1-BRCT binding extended FAAP20's role beyond core-complex recruitment to coordinating translesion polymerase delivery.

   Evidence NMR chemical shift perturbation mapping and biophysical interaction assays

   PMID:26318859

   Open questions at the time

   • Single lab, single study without in vivo Rev1 recruitment validation
   • Functional consequence for translesion synthesis not tested
7. 2015 Medium

   An in vivo mouse knockout established the organismal consequence of FAAP20 loss and the dominance of FANCA within the FAAP20-FANCA axis.

   Evidence Faap20 knockout mice with bone marrow transplantation, MMC treatment, and Fanca double-knockout epistasis

   PMID:25917546

   Open questions at the time

   • Phenotype milder than core FA components, leaving relative pathway weight uncertain
   • Single lab
8. 2016 High

   Identifying the GSK3β/SCF-FBW7 phosphodegron explained how FAAP20 levels are downregulated and showed that turnover control is itself required for proper FANCA dynamics during ICL repair.

   Evidence In vitro GSK3β kinase assay, ubiquitination assay, proteasome inhibition, and phosphomutant chromatin fractionation

   PMID:27232758

   Open questions at the time

   • Did not identify upstream signals activating GSK3β toward FAAP20
   • Single lab
9. 2019 Medium

   PIN1-catalyzed prolyl isomerization was shown to counteract the phosphodegron by recruiting PP2A, adding a stabilizing arm to FAAP20 abundance control.

   Evidence Prolyl isomerization assay, PIN1-FAAP20 and FAAP20-PP2A co-IPs, phosphomutant analysis, and ICL/FANCD2 readouts

   PMID:30789902

   Open questions at the time

   • Single lab without independent confirmation
   • Stoichiometry and dynamics relative to FBW7 not quantified
10. 2020 Medium

    Discovery of p300/CBP acetylation at K152 competing with ubiquitination at the same lysine revealed a second stabilizing mechanism and a direct switch governing FAAP20 fate.

    Evidence In vitro acetylation and ubiquitination assays, acetyl-mimetic/lysine mutants, proteasome inhibition, and FANCD2 monoubiquitination assay

    PMID:32763975

    Open questions at the time

    • Single lab
    • Signals controlling the acetylation/ubiquitination balance in vivo unknown
11. 2023 Medium

    Demonstrating FAAP20 roles in HR and SSA, including stimulation of FANCA strand annealing, broadened its function beyond ICL repair to double-strand-break processing and PARP-inhibitor sensitivity.

    Evidence HR and SSA reporter assays, in vitro FANCA strand-annealing stimulation, RAD51 foci, and IR/PARP-inhibitor survival

    PMID:37620397

    Open questions at the time

    • Single lab
    • Mechanism distinguishing FANCA-independent HR role from FANCA-dependent SSA role not fully defined

• How the multiple stability inputs (GSK3β/FBW7, PIN1/PP2A, p300/CBP acetylation) are integrated with upstream DNA-damage signaling to time FAAP20 levels during repair remains unresolved.
• No unified model linking abundance control to repair-pathway choice
• Direct disease-causing FAAP20 mutations not established in the corpus